semaglutide fda news Clears For Cardiac Risk Reduction in Diabetic Patients FDA crackdown on off-brand Ozempic

Common and Rare Adverse Effects Injection site reactions represent the most common side effects, including redness and swelling (mild, transient), bruising, mild burning or cramping reported by some users, and local irritation typically resolving within hours to days

These are some groups at higher risk for iron deficiency

GLP-1 agonists and the gut microbiome: a bidirectional relationship

Supplementation with antioxidants enhances GPx activity and decreases oxidative stress in patients with CVDs

GH secretagogues increase lipolysis and metabolic rate

BPC-157 is not approved by any drug regulatory agency for human use, and there is limited data regarding its effectiveness on humans